Article
MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors.
Virchows Archiv : an international journal of pathology - 1 Sept 2026
Kwon Jung Woo, Tjota Melissa Y, Antic Tatjana
Abstract excerpt
TSC/mTOR pathway alteration is recurrent in numerous renal tumor types, such as eosinophilic vacuolated tumor (EVT), low-grade oncocytic tumor of the kidney (LOT), and eosinophilic solid and cystic (ESC) renal cell carcinoma (RCC). Recently, additional renal tumor types with recurrent TSC/mTOR pathway mutation, such as xanthomatous giant cell RCC and RCC with leiomyomatous stroma, have also been described,...
Read the complete abstract on PubMedTopics
- Humans
- TOR Serine-Threonine Kinases
- Kidney Neoplasms
- Carcinoma, Renal Cell
- Mutation
- Chromosomes, Human, Pair 1
